ClinicalTrials.Veeva

Menu

An Evaluation of Patients Access to Their Electronic Medical Records Via the IPC Connect Application (ADN-CO)

I

Institut Paoli-Calmettes

Status

Unknown

Conditions

Hematologic Malignancy
Solid Tumor

Treatments

Other: Survey

Study type

Observational

Funder types

Other

Identifiers

NCT04496375
ADN-CO-IPC 2020-004

Details and patient eligibility

About

The aim of our study is to investigate the effect of providing patients access to their electronic medical records Via the IPC Connect Application on their A Survey will be proposed to all outpatients with a solid or hematologic malignancy who will attend an appointement at Institut Paoli Calmettes clinic.

Data will be collected during a 1-month period. The auto-questionnaire will be composed of 31 questions addressed to all patients, 17 questions will be specifically addressed to patients using IPC connect application and 7 questions will be addressed to patients who do not use the application.

Enrollment

8,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Man or woman, age> 18 Years
  • Solid tumor or hematologic malignancy
  • Patient attending an appointment at Institut Paoli Calmettes
  • Non-opposition

Exclusion criteria

  • emergency, Vulnerable person or unable to provide informed consent
  • First appointment at Institut Paoli Calmettes

Trial design

8,000 participants in 1 patient group

Institut Paoli Calmettes Outpatients
Description:
Patients with a solid tumor or an hematologic malignancy who will attend an appointement at IPC Outpatients clinic
Treatment:
Other: Survey

Trial contacts and locations

0

Loading...

Central trial contact

Dominique Genre, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems